The pharmaceutical company Emcure Pharma IPO will be hit the market July 03, 2024, and closes on July 05, 2024. The Company has filed the RHP of this IPO. According to RHP, the company wants to raise ₹1952.03 crore through IPO. The company will issue fresh shares of ₹800.00 crores through this IPO and will issue shares through offer for sale of ₹1152.03 crores.
The company has reserved 50% for QIB, 15% for NII and 35% for Retail Investor in this IPO.
Emcure Pharmaceuticals is a leading Indian pharmaceutical company engaged in developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company is a research and development (“R&D”) driven company with a differentiated product portfolio that includes orals, injectables, and biotherapeutics, which has enabled us to reach a range of target markets across over 70 countries, with a strong presence in India, Europe, and Canada.
The company ranked as the 13th largest pharmaceutical company in India in terms of Domestic Sales for the MAT Financial Year 2024, and the 4th largest pharmaceutical company by market share in our Covered Markets in terms of Domestic Sales for the MAT Financial Year 2024. You can check Emcure Pharma IPO GMP.
| Read also: Upcoming IPO List 2024 |
The company has 13 manufacturing facilities across India. The company facilities are capable of producing pharmaceutical and biopharmaceutical products across a wide range of dosage forms, including oral solids, oral liquids, injectables, liposomal and lyophilized injectables, biotherapeutics, and complex APIs.
As of September 30, 2023, Emcure Pharma employed 552 scientists and operated five research facilities in India. They filed over 1,800 documents globally, including 204 in the EU and 133 in Canada. They had 201 granted patents, 33 pending patent applications, and submitted 102 drug master files.
The company has demonstrated strong capabilities and a proven track record in building brands. Six of our brands were ranked among the 300 highest-selling brands in the IPM, in terms of Domestic Sales for MAT Financial Year 2024. The 26 brands with Domestic Sales of over ₹500.00 million for MAT Financial Year 2024, as compared to 13 brands for MAT Financial Year 2020. In addition, 16 of our top 20 brands were each ranked among the three highest-selling brands in their respective therapeutic areas in the IPM, in terms of Domestic Sales for MAT Financial Year 2024. You can check Emcure Pharma’s IPO subscription status here.
Object Of the Issue :
- Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by our Company.
- General corporate purposes.
Company Strengths :
- Well-placed to leverage our position in the domestic market.
- Demonstrated capabilities of building brands.
- Large, diversified, and fast-growing product portfolio in international markets.
- Strong R&D capabilities driving a differentiated portfolio of products.
- Extensive and diversified manufacturing capacity.
- Highly qualified, experienced, and entrepreneurial management team and Board.
Emcure Pharma IPO Review :
| Details | Valuation |
| PAT : Issue Price : EPS : PE Ratio : ROE : RoNW : ROCE : Debt/Equity : NAV Value : Total Assets : Market Cap : Pre Holding : Post Holding : | ₹527.58 Cr ₹1008 /EQ 27.54 36.60x 16.90 % 16.87 % 19.37 % 0.67 ₹163.22 ₹7,806.16 Cr ₹19029.89 Cr 98.90 % – % |
| Team Review : | ✔ Apply For Long Term |
Show Review…….
- ■ Emcure Pharmaceuticals Ltd is an Indian leading R & D driven pharmaceutical company.
- ■ The company top line strong & bottom line posted declining trends with higher provisions for interest and depreciations.
- ■ The Company PE ratio of the company is slightly high.
- ■ The company Issue price is slightly aggressive based on the PE Ratio but the company growth line is clear.
- ■ Based on FY24 the issue appears fully priced, Investors can bid the long-term investing.
Emcure Pharma IPO Date & Price Band & Details :
| IPO Open : | July 03, 2024 |
| IPO Close : | July 05, 2024 |
| Issue Type : | Book Built Issue |
| Face Value : | ₹10 Equity Share |
| Price Band : | ₹960 –1008 ₹ Per Share |
| Listing On : | BSE, NSE |
| Issue Size : | ₹1952.03. Cr {19,365,346 Shares} |
| Fresh Issue : | ₹800.00 Cr {7,936,507 Shares} |
| Offer For Sale : | ₹1152.03. Cr {11,428,839 Shares} |
| EMP Discount : | ₹90 Per Share |
Emcure Pharma IPO Market Lot :
Emcure Pharma IPO Minimum Market lot is 1 Lot with 14 shares with ₹14,112 Application amount. The retail investors can apply up to 14 lots with 196 Shares or ₹197,568 amounts.
| Application | Lot | Shares | Amount Cr |
| Retail Minimum : | 1 | 14 | ₹14,112 |
| Retail Maximum : | 14 | 196 | ₹197,568 |
| S-HNI Minimum : | 15 | 210 | ₹211,680 |
| S-HNI Maximum : | 70 | 980 | ₹987,840 |
| B- HNI Minimum : | 71 | 994 | ₹1,001,952 |
Emcure Pharma IPO Reservation :
Emcure Pharma IPO Total Reservation of 19,365,346 shares is to be bid for the public issue by Emcure Pharma IPO with 9,682,673 for QIB and 2,904,801 for NII 6,777,871 for Retail Investor & Shares EMP.
| Category | Reservation | Shares | Amount Cr |
| QIB : | 50% | 9,682,673 | ₹976.01 |
| NII : | 15% | 2,904,801 | ₹292.80 |
| RII : | 35% | 6,777,871 | ₹683.21 |
| EMP : | – | 108,900 | ₹- |
| Total : | 100% | 19,365,346 | ₹1952.03 |
Emcure Pharma IPO EPS & RoNW :
The Emcure Pharma company’s EPS & RoNW growth Increased last financial year, which is shown to you in the table here.
| Year | EPS (Rs.) | RoNW % | NAV |
| 2024 | ₹27.54 | 16.87 | ₹163.22 |
| 2023 | ₹29.42 | 21.27 | ₹138.30 |
| 2022 | ₹36.62 | 33.32 | ₹109.90 |
Emcure Pharma IPO Peer Comparison PE :
The Emcure Pharma, According to the RHP of the company is listed whose PE Multiple is shown in this table.
| Company | PE Ratio |
| Dr. Reddy’s Laboratories | 17.93 |
| Cipla | 30.10 |
| Alkem Laboratories | 33.86 |
| Torrent Pharmaceutical | 57.74 |
| Mankind Pharma | 45.30 |
| Abbott India | 47.43 |
| J. B. Chemicals & Pharmaceutical | 50.49 |
Emcure Pharma IPO Dates :
Emcure Pharma IPO Date is July 03, 2024, and closes on July 05, 2024. The allotment will be finalized on July 08, 2024, and the IPO may list on July 10, 2024.
| Anchor Date : | July 02, 2024 |
| Open Date : | July 03, 2024 |
| Close Date : | July 05, 2024 |
| Allotment Date : | July 08, 2024 |
| Refund Date : | July 09, 2024 |
| Share Credit Date : | July 09, 2024 |
| Listing Date : | July 10, 2024 |
Emcure Pharma IPO Form :
There are two ways to apply for an Emcure Pharma IPO. You can apply for Emcure Pharma IPO through ASBA available in your bank account. You have to go to your online bank login select Emcure Pharma IPO in the Invest section and apply through your bank account. Another option is you apply for Emcure Pharma IPO through an IPO form download through NSE and BSE. Visit the IPO Form Page and download the NSE Form and BSE Form IPO Form, fill it out, and submit it to your bank or your broker.
Emcure Pharma Company Financial Report (Crore) :
| Year | Revenue | Expense | PAT |
| 2024 | ₹6,715.24 | ₹5,978.08 | ₹527.58 |
| 2023 | ₹6,031.72 | ₹5,278.35 | ₹561.85 |
| 2022 | ₹5,918.86 | ₹4,946.31 | ₹702.56 |
Company Promoters :
■ Berjis Minoo Desai
Quick Link :
■ DRHP Draft Prospectus
■ RHP Draft Prospectus
■ Anchor Investor
Emcure Pharma IPO Lead Managers :
■ Axis Capital Limited
■ Kotak Mahindra Capital Company Limited
■ Jefferies India Private Limited
■ J.P. Morgan India Private Limited
Emcure Pharma IPO Registrar :
Link Intime India Private Limited
C-101, 1st Floor, 247 Park
Lal Bahadur Shastri Marg, Vikhroli (West)
Mumbai 400 083
Maharashtra, India
Tel: + 91 810811 4949
E-mail: [email protected]
Investor grievance e-mail: [email protected]
Website: www.linkintime.co.in
Note: Check Emcure Pharma IPO allotment status Visit IPOBAZAR Allotment Page And Search Your Registrar IPO Allotment Link. Click Here
Company Address :
Emcure Pharmaceuticals Limited
Plot No. P-1 & P-2, IT-BT Park, Phase-II
M.I.D.C., Hinjawadi Pune 411 057
Maharashtra, India
Tel.: + 91 20 3507 0033, + 91 20 3507 0000
E-mail: [email protected]
Website: www.emcure.com
Emcure Pharma IPO FAQs :
What is Emcure Pharma IPO?
Emcure Pharma IPO is a Mainboard IPO. They are going to raise ₹1952.03 Crores via IPO. The issue is priced at ₹960-₹1008 per equity share. The IPO is to be listed on NSE, and BSE.
When Emcure Pharma IPO will open?
The IPO is to open on July 03, 2024, to July 05, 2024, for QIB, NII & RII.
What is Emcure Pharma’s IPO Size?
Emcure Pharma’s IPO size is ₹1952.03 Crores.
What is the Fresh issue size of Emcure Pharma IPO?
The Fresh issue size of Emcure Pharma IPO ₹800.00 Cr.
What is the Offer For Sale size of Emcure Pharma IPO?
The Offer For Sale size of Emcure Pharma IPO ₹1152.03 Cr.
What is Emcure Pharma IPO Price Band?
Emcure Pharma’s IPO Price Band is ₹960-₹1008 Per share.
What is Emcure Pharma IPO Minimum and Maximum Lot Size?
The minimum of 14 Shares with ₹14,112 amount while the maximum of 196 shares with ₹197,568.
What is Emcure Pharma IPO Investors Portion?
The investors’ portion for QIB is 50%, NII 15%, and RII 35%.
What is the Emcure Pharma IPO Allotment Date?
Emcure Pharma’s IPO allotment date will be July 08, 2024.
What is the Emcure Pharma IPO Listing Date?
Emcure Pharma’s IPO listing date is July 10, 2024. The IPO to list on NSE, BSE.
How to Apply the Emcure Pharma IPO through Zerodha?
Log in to the Console on the Zerodha Website. Go to Portfolio and Click on IPO. You will see the IPO Name “Emcure Pharma IPO”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Emcure Pharma IPO through Upstox?
Log in to the Upstox Website or app. Go to Portfolio and Click on IPO. You will see the IPO Name “Emcure Pharma IPO”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Emcure Pharma IPO through Groww?
Log in to the Groww Website or app. Now you can see IPOs and Click on IPO. You will see the IPO Name “Emcure Pharma IPO”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Emcure Pharma IPO through Paytm Money?
Log in to the Paytm Money Website or app. Now you can see Invest is IPOs Section and Click on IPO. You will see the IPO Name “Emcure Pharma IPO”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
| Emcure Pharma IPO GMP: Click Here Emcure Pharma IPO Subscription: Click Here Emcure Pharma IPO Allotment: Click Here Emcure Pharma IPO Listing: Click Here Emcure Pharma IPO Web Story: Click Here |
All Emcure Pharma IPO-related links are available here. If you want to know the details then click on the Click Here Link.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME-RELATED DOCUMENTS CAREFULLY BEFORE INVESTING.